Dubai PR Network, Online Press Release from Dubai and Middle East
Health & Fitness(Healthcare & Medicine)
Filter PR by
Euronews Speaks to CEO of Abu Dhabi-based Company Developing COVID-19 Vaccine

The exclusive interview with Ashish Koshy is now available to watch on Euronews’ Inspire Middle East channel


Dubai, United Arab Emirates, 22nd July 2020:  Europe’s number one leading news channel, Euronews, sat down with Ashish Koshy, the CEO of Group 42, an Abu Dhabi-based artificial intelligence and cloud computing company that is currently involved in the development of a COVID-19 vaccine. The interview comes as health authorities of Abu Dhabi and Beijing announce the start of the world’s first phase three clinical trial of a vaccine to treat the novel coronavirus.

Ashish Koshy commented on the high expectations of his company’s work: “It's a global effort together against this global pandemic. Every country needs to play its part in participating and not in a race, but in a collaborative effort to fight against this global pandemic. That is definitely not just a global health crisis, but also it is hitting economies, jobs, airlines. And that's what it should be considered as, a global effort towards combating this pandemic.”

With the UAE known for having one of the highest testing rates for COVID-19 in the world, Abu Dhabi has become home to a high-volume testing center, the first of its kind outside of China with the capacity to diagnose thousands of people every day.

When asked why the UAE collaborated with China to develop a vaccine, Ashish Koshy said: “Sinopharm has two products, two inactivated vaccines in the top ten race and that's essentially the synergy we saw. It felt like definitely a strong partner that we could bring into the UAE, bring the capability into the UAE, and give early access to the UAE residents.”
Regarding Group 42’s current work focused on virus mutation, Ashish Koshy said: “In our genomics laboratory, we are currently doing COVID-19 sequencing and the purpose of this sequencing is purely just to understand the mutation pattern of the vaccines across not just the viral genomes, but also the human hosts to figure out how the virus mutating.”
He added: “We developed a new platform called Group42 AI platform where we have a complete bioinformatics pipeline to showcase and identify patterns specifically from this immediately, once the clinical phase three trials start up. We have a plethora of data where people can plug in and come up with incredible insights that could figure out how the virus is mutating and thus, potentially – the vaccine have an answer to cure that.”

Ashish Koshy is hopeful that a vaccine might enter the market by the end of this year or early 2021. He explained the next steps of Group 42’s research after phase three is completed: “We are targeting at least a group of 5,000 or more and I am sure the results can be positive enough to move to phase four. What happens in phase four is we would get FDA approval, assuming the results from the clinical phase three trials are positive for FDA approval and eventually the production, distribution and manufacturing.” 

Posted by : Dubai PR Network Editorial Team
Viewed 2989 times
PR Category : Healthcare & Medicine
Posted on : Wednesday, July 22, 2020  4:45:00 PM UAE local time (GMT+4)
Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of
Previous Story : SCCI Discusses Post-Covid-19 Economic Cooperation with Rwand...
Next Story : Six Effective Ways to Protect Your Eyes During Summer
Email this article Print this article

Share this article with your friends and followers
Back to Section Home

Related Stories

Most Viewed Press Release posted in the last 7 days
Make Up for Ever Introduces for the First Time Its New Active Care-in-foundation to Revive... [5961-Views]
HONOR 2020 H1 Business Achievements in International Markets [3817-Views]
Here's Why A Silicone Cleansing Brush Champions Other Cleansing Tools and Techniques [3382-Views]
Panasonic Jaguar Racing Head to Berlin for a Lockdown Showdown [3177-Views]
Samsung Launches Galaxy Watch3 and Galaxy Buds Live [3095-Views]
Save up to AED 25,000 on Pre-Owned Lexus Cars with Al-Futtaim Auto Fest [3067-Views]
Get Your No-MakeUp MakeUp Look With Hourglass [3046-Views]
Safe Start-up of Unit 1 of Barakah Nuclear Energy Plant Successfully Achieved [2948-Views]
Parmigiani Fleurier Tonda 1950 Tourbillon [2632-Views]
Schneider Electric Shows They Are Acting to Build a Green and Inclusive Future for All Thr... [2599-Views]
Sony Middle East & Africa Announces ‘Ready for PlayStation®5' for current BRAVIA™ TVs [2517-Views]
UAE Team Emirates Back to Winning Ways [2308-Views]
Lacoste Launches the Roland - Garros Eyewear Collection [2304-Views]
Introducing the New Omega Constellation Gents' Collection' [2288-Views]
Pre-Orders for Samsung's Galaxy Note20 and Galaxy Note20 Ultra Now Open in the UAE [2148-Views]
Jafza Sets a New Benchmark With ‘collaboration for Safe and Sustainable Growth' Webinar' [2128-Views]
Up to €500,000 to Support the Most Promising Innovators: The Agrofood BIC Accelerator Issu... [1968-Views]
The Last Few Weeks of Dubai Shopping Mall Group's Summer Promotion [1960-Views]
Dubai Sports Council and Ski Dubai to Host One of the World's First Snow Sports Competitio... [1952-Views]
Kia Motors Collects Over 2,000 Pairs of Football Boots via UEFA Europa League Trophy Tour ... [1919-Views]
Cebu Pacific Advisory: Suspension of Domestic Passenger Flights to/from Manila – Aug 4 to ... [1919-Views]
The Best Just Got Better – Sony Middle East & Africa Announces WH-1000XM4 Industry-Leading... [1792-Views]
New Month, New Goals [1788-Views]
No Premium Without Responsibility: BMW Group Makes Sustainability and Efficient Resource M... [1771-Views]
Post-COVID Travel is Set to Become Smarter. Here's How. [1771-Views]
RSS Facebook Twitter LinkedDin
Top Sections
Top Stories